SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
By Julian Braun, L. Loyal, M. Frentsch, D. Wendisch, Philipp Georg, F. Kurth, S. Hippenstiel, M. Dingeldey, B. Kruse, F. Fauchère and 23 more. Nature, 2020
1,119 citations recorded by the source corpus.
Subfields: Infectious Diseases, Modeling and Simulation
View Paper: https://www.semanticscholar.org/paper/8adfb8bbcca12a38c56ea94e050ee36e51f63f1c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Modeling and Simulation
Citations in the corpus
- Adaptive immunity to SARS-CoV-2 and COVID-19 (2021, background): “862 Cell 184, February 18, 2021 Ineffective IFN innate immunity has been strongly associated with failure to control a primary SARS-CoV-2 infection and a high risk of fatal COVID-19, accompanied by innate cell immunopathology and a plasma cytokine signature of elevated CXCL10, interleukin (IL)-6, an”
- Preexisting and de novo humoral immunity to SARS-CoV-2 in humans (2020, background): “Together with pre-existing T cell (12-14) and B cell memory (10, 15), antibody cross-reactivity between seasonal HCoVs and SARSCoV-2 may have important ramifications for natural infection.”
- COVID-19 and the human innate immune system (2021, background): “…perspective and assuming that the majority of humankind does not have an extended cross-reaction to other viruses of the coronavirus family (Braun et al., 2020; Grifoni et al., 2020; Mateus et al., 2020), the introduction of SARS-CoV-2 into the human population is one of the biggest…”
- Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment (2020, positive): “SARS-CoV-2 infection induces specific T cell and B cell responses, which is reflected by elevation of SARS-CoV-2 peptide-specific T cells (Braun et al., 2020; Grifoni et al., 2020) and the production of SARS-CoV-2-specific antibodies (Long et al.”